NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wondercel Therapeutics

Wondercel Therapeutics

Private
ShenzhenHealthcare & Life Scienceshttps://www.wondercel.com/index

Last Round

Series A

Jul 10, 2026

Total Funding Raised

$33.4M

Company Overview

Wondercel Therapeutics is a biotechnology company that develops universal CAR-T cell therapy platforms for the treatment of cancer, organ transplantation, and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T therapyallogeneic cell therapyoff-the-shelf cell therapybiotechnologyimmune cell therapycell therapy manufacturinginduced regulatory T celliTregimmune tolerancesolid tumor therapyhematologic malignanciesuniversal CAR-Tbiologicsclinical trialsnext-gen cell therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wondercel Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Wondercel Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wondercel Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 10, 2026
AngelFeb 10, 2023

Wondercel Therapeutics Investors

Notable investors and investment history

Wondercel Therapeutics investors
InvestorRounds
Oriental Fortune CapitalSeries A
YuanBio Venture CapitalAngel
松禾资本 (Green Pine Capital Partners)Series A

Wondercel Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wondercel Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wondercel Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Year Founded2022
Last FundingJul 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.